Clinical Trials · NCT03972488
Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Advanced Accelerator Applications
- Enrollment
- 226
- Start date
- Jan 2020
- Locations
- 40 sites, 9 countries
- Primary endpoint
- Progression Free Survival (PFS) Per Central Assessment